publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
virolog
research
current
use
biomed
research
laboratori
primat
viral
infect
respons
signific
morbid
mortal
human
influenza
pandem
respons
million
death
worldwid
decemb
million
peopl
infect
hiv
onethird
infect
dead
emerg
infecti
diseas
often
viral
etiolog
evidenc
recent
outbreak
newli
discov
coronaviru
produc
sever
acut
respiratori
syndrom
sar
epidem
asia
north
america
monkeypox
us
chronic
infect
hepat
b
c
virus
herp
virus
also
signific
public
health
threat
remain
forseeabl
futur
clearli
viral
infect
remain
signific
threat
human
health
thu
consider
effort
expend
develop
vaccin
therapeut
control
acut
persist
viral
infect
outcom
human
viral
infect
depend
complex
interact
viru
host
genet
polymorph
human
popul
dose
strain
rout
viru
inocul
contribut
wide
rang
clinic
outcom
viral
infect
studi
viral
pathogenesi
preclin
develop
viral
vaccin
therapeut
requir
use
anim
model
exquisit
specif
virus
cellular
receptor
absolut
requir
virus
appropri
intracellular
machineri
defin
host
cell
tropism
virus
explain
virus
tend
adapt
infect
particular
host
speci
rel
genet
homolog
human
nonhuman
primat
nhp
mean
consider
conserv
critic
molecul
use
virus
life
cycl
thu
nhp
often
speci
infect
human
pathogen
altern
number
virus
endem
nhp
distinct
close
relat
human
pathogen
good
model
relat
human
infect
develop
genet
function
anatomi
immun
system
nonhuman
primat
human
similar
make
nonhuman
primat
use
understand
human
immun
excel
review
document
histor
role
nhp
viral
research
renegar
soik
et
al
includ
critic
role
monkey
play
elucid
pathogenesi
polioviru
develop
polioviru
vaccin
sabin
review
focu
contemporari
studi
employ
nhp
model
viral
diseas
current
greatest
public
health
concern
hantaviru
hantaviru
genu
hantaviru
famili
bunyavirida
infect
human
associ
two
sever
potenti
fatal
diseas
hemorrhag
fever
renal
syndrom
hfr
associ
primarili
hantavirus
found
europ
asia
character
fever
thrombocytopenia
renal
failur
sever
case
hemorrhag
due
increas
capillari
permeabl
lee
et
al
hantaviru
pulmonari
syndrom
hp
associ
infect
hantavirus
indigen
america
eg
and
muerto
canyon
sin
nombr
virus
character
fever
myalgia
rapid
onset
sever
respiratori
distress
nichol
et
al
mortal
associ
hp
lednicki
reservoir
hantavirus
specif
rodent
host
persist
nonpathogen
infect
common
lednicki
schmaljohn
hjell
transmiss
human
inhal
aerosol
rodent
urin
fece
mcelroy
et
al
human
human
transmiss
hantaviru
document
case
hp
caus
and
viru
padula
et
al
effect
hantaviru
vaccin
develop
virus
caus
hfr
respond
antivir
therapi
ribivarin
current
effect
antivir
drug
therapi
hp
chapman
et
al
sever
speci
nhp
suscept
experiment
infect
hantavirus
groen
et
al
yanagihara
et
al
nhp
model
emerg
valuabl
tool
investig
hantaviru
pathogenesi
evalu
antivir
therapi
candid
vaccin
experiment
infect
cynomolgu
macaqu
puumala
viru
produc
typic
sign
hfr
includ
lethargi
anorexia
proteinuria
andor
hematuria
along
cytokin
creatinin
nitric
oxid
creactiv
protein
respons
similar
human
hfr
klingstrom
et
al
nhp
model
also
use
evalu
candid
hantaviru
vaccin
prototyp
dna
vaccin
hantavirus
caus
hfr
elicit
high
titer
neutral
antibodi
rhesu
macaqu
hooper
et
al
first
attempt
develop
model
hp
cynomolgu
macaqu
experiment
infect
and
viru
intraven
aerosol
rout
viremia
detect
rtpcr
expos
anim
none
develop
clinic
sign
hp
one
anim
develop
decreas
baselin
platelet
count
coincid
high
viremia
consist
thrombocytopenia
seen
human
hfr
anim
howev
show
significantli
reduc
lymphocyt
count
develop
igm
igg
antibodi
viral
nucleocapsid
protein
neutral
antibodi
titer
mcelroy
et
al
futur
refin
primat
model
greatli
facilit
progress
treatment
prevent
hantavirusrel
diseas
ebola
viru
famili
filovirida
respons
outbreak
hemorrhag
fever
high
mortal
human
nhp
evan
et
al
walsh
et
al
mani
speci
nhp
suscept
experiment
infect
ebola
viru
outcom
almost
uniformli
fatal
lethal
ebola
viru
infect
primat
use
support
conclus
nhp
natur
reservoir
host
ebola
natur
cours
ebola
viru
infect
nhp
close
follow
observ
infect
human
baskervil
et
al
johnson
et
al
jaax
et
al
result
nonhuman
primat
use
extens
studi
ebola
viru
pathogenesi
baskervil
johnson
et
al
jaax
et
al
riyabchikova
et
al
ignatiev
et
al
studi
rhesu
cynomolgu
macaqu
demonstr
lethal
ebola
viru
infect
occur
oral
conjunctiv
aerosol
rout
exposur
jahrl
et
al
johnson
e
et
al
experiment
infect
african
green
monkey
baboon
confirm
macrophag
monocyt
first
cell
infect
play
major
role
subsequ
system
distribut
viru
riyabchikova
et
al
experiment
studi
also
document
absenc
inflammatori
respons
ebola
virusinfect
nhp
baskervil
et
al
jaax
et
al
suggest
virusinduc
impair
immun
function
studi
baboon
shown
sever
ebola
virusinduc
coagulopathi
correl
increas
serum
level
interferon
tumor
necrosi
ignatiev
et
al
interestingli
differ
observ
ebola
viru
pathogenesi
differ
speci
nonhuman
primat
follow
infect
ebolazair
baboon
develop
sign
hemorrhag
diseas
african
green
monkey
given
dose
develop
gener
fibrin
thrombosi
absenc
overt
hemorrhag
riyabchikova
et
al
find
indic
speciesspecif
differ
need
consid
select
nhp
model
ebola
viru
infect
use
differ
model
system
may
necessari
address
entir
spectrum
human
diseas
associ
ebola
viru
infect
nhp
model
also
figur
promin
effort
develop
ebola
viru
vaccin
sullivan
et
al
sullivan
et
al
passiv
immun
cynomolgu
macaqu
hyperimmun
globulin
alon
combin
recombin
protect
geisbert
et
al
jaax
et
al
jahrl
et
al
jahrl
et
al
similarli
cynomolgu
macaqu
immun
liposomeencapsul
irradi
ebola
viru
produc
virusneutr
antibodi
protect
lethal
challeng
suggest
humor
cellmedi
immun
requir
protect
rao
et
al
newer
approach
vaccin
develop
focus
induct
cellular
humor
immun
respons
incorpor
use
dna
vaccin
primeboost
protocol
combin
dna
immun
follow
boost
recombin
adenovir
vector
express
ebola
viral
protein
induc
cellular
humor
immun
respons
cynomolgu
macaqu
immun
anim
complet
protect
lethal
challeng
ebolazair
indic
prevent
vaccin
ebola
viru
feasibl
sullivan
et
al
primeboost
protocol
effect
prevent
vaccin
regimen
requir
month
complet
preclud
use
control
acut
epidem
sullivan
et
al
recent
studi
demonstr
immun
cynomolgu
macaqu
recombin
adenoviru
vector
encod
ebola
viru
glycoprotein
nucleoprotein
absenc
dna
prime
result
earlier
antibodi
product
induct
ebola
virusspecif
tcell
respons
monkey
immun
singl
dose
construct
challeng
day
later
complet
protect
high
lowdos
viral
challeng
sullivan
et
al
diseas
potenti
patholog
respiratori
pathogen
differ
primat
rodent
anim
model
two
major
reason
first
anatomi
develop
respiratori
system
rodent
significantli
differ
human
nonhuman
primat
plopper
et
al
second
mani
virus
pathogen
human
also
pathogen
anoth
primat
speci
rodent
mainli
due
need
specif
host
cell
factor
viral
replic
respiratori
viru
infect
human
model
wide
rang
primat
includ
chimpanze
belsh
et
al
hancock
et
al
teng
et
al
macaqu
blake
trask
bukreyev
et
al
fouchier
et
al
ponnuraj
et
al
rimmelzwaan
et
al
van
den
hoogen
et
al
zaucha
et
al
african
green
monkey
durbin
et
al
kakuk
et
al
recent
two
new
viral
pathogen
pneumoviru
coronaviru
respons
sever
acut
respiratori
syndrom
success
transmit
cynomolgu
monkey
help
establish
etiolog
newli
discov
respiratori
tract
infect
fouchier
et
al
van
den
hoogen
et
al
primat
model
use
mani
year
studi
respiratori
tract
infect
immun
measl
viru
figur
blake
trask
putz
et
al
influenza
renegar
rimmelzwaan
et
al
soik
et
al
parainfluenza
durbin
et
al
hall
et
al
schmidt
et
al
respiratori
syncyti
viru
belsh
et
al
cheng
et
al
hancock
et
al
kakuk
et
al
leaman
et
al
teng
et
al
recent
monkeypox
zaucha
et
al
major
publish
work
focus
vaccin
develop
possibl
best
studi
exampl
differ
host
speci
pathogen
henc
use
anim
model
case
measl
viru
rodent
primat
anim
model
use
measl
vaccin
research
wildtyp
strain
measl
viru
replic
rodent
speci
except
cotton
rat
vaccineinduc
protect
immun
test
human
suscept
nonhuman
primat
putz
et
al
similar
restrict
concern
anim
model
influenza
viru
renegar
soik
et
al
primat
model
play
critic
role
understand
problem
enhanc
atyp
lung
diseas
occur
children
vaccin
wholeinactiv
viral
vaccin
measl
respiratori
syncyti
viru
children
expos
wildtyp
viru
vaccineinduc
immunopatholog
extens
model
mice
type
cell
found
play
pivot
role
graham
et
al
howev
laboratori
mous
permiss
measl
respiratori
syncyti
viru
replic
question
protect
versu
immunopatholog
vaccin
immun
address
primat
model
use
nonhuman
primat
model
shown
hypersensit
reaction
larg
respons
enhanc
patholog
associ
respiratori
syncyti
viru
infect
immun
formalininactiv
rsv
vaccin
de
swart
et
al
kakuk
et
al
ponnuraj
et
al
studi
macaqu
demonstr
role
immun
complex
eosinophil
pathogenesi
atyp
measl
polack
et
al
chronic
viral
infect
character
abil
pathogen
evad
host
antivir
immun
cours
year
reflect
highli
evolv
relationship
host
viru
involv
interact
numer
viral
protein
host
immun
system
highli
evolv
relationship
also
mean
human
chronic
viral
pathogen
often
infect
nhp
thu
homolog
viral
pathogen
primat
use
model
human
viral
diseas
model
chronic
viral
diseas
anim
speci
must
longliv
possess
immun
system
highli
homolog
human
primat
tlymphotrop
virus
ptlv
compris
close
relat
group
retrovirus
oncoviru
subfamili
retrovirida
includ
virus
human
nhp
first
member
group
identifi
human
tlymphotrop
viru
typei
htlvi
isol
blood
patient
adult
tcell
leukemialymphoma
atll
poiesz
et
al
htlvi
human
retroviru
known
oncogen
etiolog
link
viru
atll
well
establish
johnson
jm
et
al
infect
also
etiolog
associ
chronic
progress
myelopathi
known
tropic
spastic
associ
myelopathi
tspham
levin
jacobson
specif
mechan
underli
pathogenesi
host
immun
respons
complet
understood
current
vaccin
prevent
infect
effect
treatment
malign
dekaban
et
al
franchini
franchini
streicher
member
ptlv
group
includ
kalyanaraman
et
al
human
viru
conclus
link
cancer
cognat
simian
tlymphotrop
virus
type
kalyanaraman
et
al
meerten
gessain
miyoshi
et
al
nhp
natur
acquir
infect
stlvi
induc
leukemia
lymphoma
predominantli
african
speci
mani
clinic
patholog
similar
atll
tsujimoto
et
al
human
simian
lymphoma
occur
small
proport
infect
individu
usual
prolong
period
latenc
blattner
tsujimoto
et
al
date
counterpart
tspham
recogn
nhp
two
approach
use
develop
util
nhp
model
human
htlvi
infect
diseas
one
approach
take
advantag
fact
sever
speci
nhp
suscept
experiment
infect
htlvi
includ
variou
speci
macaqu
beilk
et
al
ibuki
et
al
murata
et
al
squirrel
monkey
kazanji
kazanji
et
al
common
marmoset
yamanouchi
et
al
experiment
infect
japanes
macaqu
fuscata
use
demonstr
efficaci
passiv
immun
hypreimmun
serum
prevent
htlvi
infect
murata
et
al
cynomolgu
macaqu
model
use
demonstr
longterm
persist
protect
immun
follow
immun
recombin
vaccinia
viru
express
htlvi
envelop
gene
ibuki
et
al
although
nhp
infect
htlvi
develop
tumor
htlvirel
patholog
condit
includ
polymyos
uveiti
arthriti
observ
rhesu
macaqu
follow
experiment
infect
htlvi
beilk
et
al
squirrel
monkey
model
use
investig
distribut
viru
variou
tissu
earli
htlvi
infect
relationship
viral
gene
express
host
humor
cellular
immun
respons
infect
kazanji
kazanji
et
al
infect
common
marmoset
htlvi
oral
rout
provid
support
concept
milkborn
infect
htlviinfect
mother
nurs
infant
yamanouchi
et
al
anoth
approach
primat
model
develop
exploit
natur
occur
infect
mani
speci
old
world
nhp
share
high
degre
genet
related
dekaban
et
al
rout
transmiss
lazo
et
al
cours
infect
primat
parallel
human
tsujimoto
et
al
respect
hostviru
system
give
rise
similar
proport
malign
tumor
induc
indistinguish
human
atll
mccarthi
et
al
tsujimoto
et
al
method
replic
name
clonal
expans
viru
infect
tcell
virtual
ident
morteaux
et
al
exact
mechan
ptlv
oncogenesi
fulli
elucid
result
recent
studi
suggest
malign
transform
atll
multihit
phenomenon
mark
discreet
genet
event
arima
tei
tax
gene
present
thought
play
major
role
leukemogenesi
due
pleiotrop
action
dekaban
et
al
franchini
franchini
streicher
includ
transcript
suppress
dna
polymeras
jeang
et
al
function
suppress
gene
import
regul
cell
cycl
matsuoka
infect
nonhuman
primat
provid
excel
model
system
investig
mechan
ptlv
oncogenesi
vivo
two
decad
nhp
model
aid
especi
simian
immunodefici
viru
siv
infect
macaqu
provid
import
insight
transmiss
pathogenesi
aid
well
virusspecif
immun
respons
antisiv
vaccin
regimen
although
effect
vaccin
human
aid
yet
avail
signific
progress
made
toward
goal
review
robinson
studi
primat
lentiviru
transmiss
nhp
model
permit
dissect
earliest
event
occur
infect
host
exposur
viru
defin
condit
includ
effect
viral
inoculum
dose
viral
virul
rout
exposur
review
pope
haas
experi
nhp
also
determin
tempor
relationship
lentivir
replic
known
viru
exposureinfect
system
infect
develop
antivir
immun
respons
diseas
progress
perhap
import
vaccin
develop
nhp
studi
compar
lentivirusspecif
immun
respons
earli
viru
exposur
vaccin
unvaccin
anim
assess
potenti
correl
vaccinemedi
protect
review
mcmichael
hank
result
experi
begun
identifi
key
strategi
could
use
reduc
elimin
hiv
transmiss
one
infect
person
anoth
understand
area
essenti
develop
vaccin
prevent
human
hiv
infect
aid
studi
neither
feasibl
ethic
human
mani
african
nhp
speci
natur
infect
speciesspecif
siv
variant
endem
siv
infect
appar
result
aid
asian
macaqu
natur
infect
siv
experiment
inocul
macaqu
siv
variant
isol
african
monkey
result
aid
review
gardner
number
macaqu
baboon
speci
use
transmiss
pathogenesi
vaccin
studi
locher
et
al
infect
macaqu
siv
hybrid
sivhiv
virus
contain
envelop
shiv
gener
accept
practic
nhp
model
human
hivinfect
aid
wide
use
evalu
vaccin
strategi
aid
review
letvin
et
al
mcchesney
et
al
mcmichael
hank
robinson
wellestablish
capac
primat
lentiviru
caus
immunodefici
diseas
asian
macaqu
speci
associ
abil
replic
high
level
establish
system
infect
mcchesney
et
al
although
sever
biolog
properti
includ
coreceptor
use
growth
transform
cell
line
primari
macaqu
blood
cell
propos
account
virul
siv
shiv
isol
demonstr
none
reliabl
predict
abil
induc
aid
infect
macaqu
tabl
persist
high
viral
replic
measur
high
level
viral
rna
core
antigen
plasma
also
best
predictor
reliabl
transmiss
mucos
exposur
siv
shiv
isol
tabl
develop
countri
infant
formula
readili
avail
breastfeed
essenti
infant
surviv
vertic
hiv
transmiss
prevent
effect
antiretrovir
treatment
pregnanc
deliveri
combin
short
cours
antiretrovir
drug
given
newborn
howev
develop
nation
even
prenat
care
limit
access
antiretrovir
drug
altern
breast
feed
formula
clean
water
rare
avail
afford
mboringacha
et
al
set
exposur
breast
milk
remain
major
risk
hiv
infect
neonat
vaccin
protect
hiv
breast
milk
transmiss
urgent
need
evalu
strategi
may
prevent
hiv
infect
breast
feed
hiv
breast
milk
transmiss
model
infant
rhesu
macaqu
direct
model
sivinfect
pregnant
macaqu
allow
suckl
infant
earli
studi
use
model
found
low
unreli
siv
transmiss
infant
mcclure
et
al
recent
amede
colleagu
amede
et
al
report
effici
breast
milk
transmiss
siv
infant
sivinfect
dam
limit
model
durat
breast
feed
siv
infect
infant
vari
week
month
associ
level
viral
rna
milk
amede
et
al
conserv
adult
femal
macaqu
need
breed
better
control
viral
host
variabl
altern
macaqu
model
hiv
breast
milk
transmiss
oral
siv
shiv
inocul
newborn
infant
macaqu
may
nurseryrear
advantag
experiment
oral
viru
inocul
includ
abil
use
specif
dose
wellcharacter
viru
inoculum
vari
total
number
viru
exposur
interv
viru
exposur
assess
infant
develop
may
modul
outcom
viru
exposur
disadvantag
need
laborintens
nurseri
rear
sivexpos
infant
macaqu
special
contain
facil
increas
clinic
care
veterinari
staff
sivinfect
infant
absenc
antimicrobi
factor
normal
present
macaqu
breast
milk
may
close
mimic
condit
found
breast
milk
hivinfect
women
farquhar
et
al
studi
use
oral
inocul
infant
macaqu
siv
shiv
demonstr
antiretrovir
drug
van
rompay
et
al
hiv
neutral
monoclon
antibodi
baba
et
al
hofmannlehmann
et
al
passiv
acquir
sivspecif
nonneutr
antibodi
van
rompay
et
al
prevent
infect
given
case
soon
viru
exposur
recent
van
rompay
colleagu
van
rompay
et
al
shown
activ
immun
infant
rhesu
macaqu
liveattenu
siv
recombin
poxviru
vector
express
siv
structur
protein
protect
high
viremia
delay
onset
aid
oral
inocul
virul
siv
collect
result
studi
use
sivinf
macaqu
model
suggest
passiv
activ
immun
strategi
may
success
reduc
breast
milk
transmiss
hiv
major
histocompat
complex
mhc
play
essenti
role
immun
respons
viral
infect
enorm
variat
observ
human
mhc
gene
thought
reflect
select
pressur
microbi
especi
viral
pathogen
consensu
mhc
allel
carrington
bontrop
haplotyp
significantli
modul
rate
progress
aid
hivinfect
peopl
carrington
carrington
obrien
cullen
et
al
cullen
et
al
trachtenberg
et
al
addit
concord
mhc
class
allel
hivinfect
women
infant
associ
increas
risk
vertic
hiv
transmiss
polycarp
et
al
evid
specif
human
mhc
allel
influenc
respons
hivinfect
immun
hiv
vaccin
kaslow
et
al
even
propos
rel
low
genet
variat
mhc
class
chimpanze
direct
result
longterm
select
ancient
siv
devast
pandem
wild
chimpanze
de
groot
et
al
contrast
chimpanze
recent
studi
mhc
asian
macaqu
indic
allel
haplotyp
variat
among
individu
anim
similar
greater
mhc
variat
observ
human
doxiadi
et
al
also
shown
hivinfect
human
rhesu
mhc
allel
haplotyp
report
influenc
rate
diseas
progress
sivinfect
anim
carrington
bontrop
oconnor
et
al
pal
et
al
sauermann
et
al
may
modul
vaccin
protect
siv
challeng
oconnor
et
al
pal
et
al
observ
underscor
need
identifi
mhc
allel
defin
complet
mhc
halplotyp
nhp
speci
use
aid
vaccin
develop
friedrich
watkin
sauermann
moder
low
none
low
low
low
low
low
done
ultim
test
relev
util
nhp
model
aid
hiv
vaccin
develop
accuraci
predict
efficaci
specif
vaccin
strategi
human
clinic
trial
date
result
singl
clinic
trial
hiv
vaccin
efficaci
avail
comparison
efficaci
observ
nhp
model
doubleblind
placebo
control
human
trial
jointli
sponsor
nih
vaxgen
found
overal
efficaci
clade
b
hiv
recombin
protein
vaccin
group
highrisk
hiv
exposur
usa
ie
statist
signific
differ
individu
receiv
placebo
vaccin
either
proport
individu
becom
hivinfect
viral
load
infect
cohen
cohen
outcom
mirror
prior
nhp
efficaci
trial
recombin
hiv
envelop
chimpanze
challeng
nonhomolog
laboratori
isol
girard
et
al
macaqu
immun
recombin
hiv
envelop
exampl
show
littl
protect
infect
parenter
mucos
challeng
pathogen
siv
shiv
isol
review
robinson
result
expect
avail
end
second
larg
human
clinic
trial
assess
efficaci
recombin
canarypox
vector
express
hiv
envelop
structur
regulatori
protein
given
primari
immun
follow
recombin
hiv
envelop
protein
booster
immun
preclin
studi
macaqu
immun
recombin
canarypox
express
siv
andor
hiv
antigen
found
despit
modest
level
virusspecif
immun
respons
vaccin
anim
reduc
viral
load
slower
diseas
progress
compar
unvaccin
control
challeng
review
robinson
result
nhp
efficaci
studi
consist
reflect
human
trial
similar
hiv
vaccin
strategi
reinforc
valu
relev
nhp
model
aid
hiv
vaccin
develop
especi
identifi
immun
correl
perhap
understand
mechan
hiv
vaccin
efficaci
use
nhp
model
human
cytomegaloviru
hcmv
expand
dramat
last
year
increas
appreci
impact
hcmv
infect
human
health
hcmv
member
herpesvirida
famili
virus
mocarski
recogn
year
seriou
threat
develop
fetu
caus
wide
spectrum
patholog
outcom
weller
hcmv
also
major
caus
morbid
mortal
either
aid
immunosuppress
immun
system
alford
britt
licens
vaccin
hcmv
although
longstand
recognit
medic
need
one
committe
studi
prioriti
vaccin
develop
medicin
hcmv
speciesspecif
grow
nhp
avail
studi
limit
experiment
investig
tissu
cultur
set
natur
histori
studi
human
leav
mani
experiment
question
unansw
howev
nhp
model
ideal
suit
fill
experiment
void
concern
mani
critic
aspect
hcmv
natur
histori
develop
novel
immunolog
chemotherapeut
strategi
either
prevent
infect
limit
diseas
vast
major
studi
involv
infect
rhesu
macaqu
rhesu
cmv
rhcmv
howev
import
observ
also
made
cmv
macaqu
speci
african
green
monkey
baboon
chimpanze
simian
system
also
relev
surrog
hcmv
review
prototyp
simian
cmv
phenotyp
present
base
studi
differ
nhp
cmv
compar
studi
differ
nhp
cmv
extrem
limit
stress
cmv
repres
coevolv
host
speci
accordingli
evolut
virushost
relationship
may
led
import
yet
undiscov
distinct
differ
cmv
isol
cmv
isol
multipl
genera
speci
old
new
world
nhp
host
asher
et
al
black
et
al
eizuru
et
al
probabl
everi
nhp
speci
associ
speciesspecif
cmv
analys
genom
protein
express
serolog
crossrelated
demonstr
cmv
isol
differ
nhp
speci
uniqu
host
davison
aj
et
al
eizuru
et
al
gibson
hansen
et
al
kilpatrick
et
al
minamishima
et
al
tinghitella
et
al
evid
date
cmv
one
host
speci
grow
anoth
host
speci
follow
natur
exposur
howev
simian
cmv
replic
vitro
restrict
cell
host
speci
cmv
african
green
monkey
black
et
al
rh
cmv
alcendor
et
al
product
infect
human
nhp
cell
cultur
agmcmv
product
infect
rhesu
macaqu
replic
year
swack
et
al
expans
nhp
cmv
sequenc
genbank
possibl
confirm
speci
ident
primari
isol
limit
sequenc
analysi
like
hcmv
simian
cmv
common
infecti
agent
nhp
popul
andrad
et
al
black
et
al
eizuru
et
al
kessler
et
al
minamishima
et
al
swack
hsiung
swack
et
al
vogel
et
al
virtual
monkey
breed
facil
seroposit
one
year
age
infant
seroposit
month
age
vogel
et
al
like
multipl
strain
cmv
present
within
breed
facil
alcendor
et
al
compar
rate
seropreval
report
monkey
trap
wild
eizuru
et
al
minamishima
et
al
ohtaki
et
al
swack
et
al
rout
transmiss
known
like
viru
horizont
transmit
mother
infant
via
breast
milk
saliva
similar
identifi
mode
human
viru
also
normal
excret
urin
ad
anoth
rout
viru
spread
evid
consist
transmiss
utero
although
low
rate
exclud
vogel
et
al
maternalfet
transmiss
critic
compon
hcmv
congenit
transmiss
one
aspect
hcmv
natur
histori
model
nhp
time
like
absenc
congenit
infect
nhp
high
seropreval
hcmv
breed
age
femal
cmv
seropreval
chang
dramat
anim
rear
smaller
cohort
birth
infant
separ
dam
soon
birth
hand
rear
nurseri
anim
remain
essenti
cmvfree
well
past
age
sexual
matur
barri
unpublish
minamishima
et
al
simian
cmv
infect
immunocompet
host
either
experiment
follow
natur
exposur
result
clinic
sign
diseas
similar
vast
major
hcmv
infect
mononucleosi
rel
rare
outcom
primari
hcmv
infect
never
associ
cmv
infect
nhp
addit
publish
report
anecdot
observ
cmv
diseas
monkey
cull
die
reason
acquir
immunodefici
immunosuppress
conclud
absenc
diseas
host
immun
respons
primari
cmv
infect
highli
protect
gener
cours
primari
infect
seroneg
host
involv
rapid
dissemin
site
infect
distal
site
throughout
bodi
lockridg
et
al
monkey
natur
expos
cmv
viru
probabl
transmit
across
oral
genit
mucosa
experiment
inocul
done
oral
intraven
subcutan
sc
rout
viral
dna
gener
detect
blood
within
day
infect
multipl
tissu
within
two
week
lockridg
et
al
antivir
immun
respons
rapid
increas
intens
viral
plasma
dna
load
decreas
cellular
antivir
respons
follow
cours
develop
humor
respons
varieti
hematolog
chang
follow
experiment
iv
inocul
although
consist
pattern
observ
lockridg
et
al
two
promin
hallmark
persist
phase
rcmv
infect
chronic
viral
shed
stabil
antivir
immun
respons
characterist
ident
hcmv
infect
monkey
remain
viuric
year
follow
primari
infect
probabl
life
host
asher
et
al
swack
hsiung
frequenc
cmv
shed
variabl
anim
although
monkey
appear
constantli
shed
infecti
viru
oral
genit
mucosa
histor
shed
assay
cultur
viru
recent
sensit
molecular
techniqu
realtim
pcr
use
detect
quantifi
cmv
dna
purifi
mucos
swab
approxim
seroposit
monkey
dnaposit
mucos
fluid
one
time
thu
activ
ongo
viru
replic
mucos
surfac
within
persist
infect
host
occasion
antigenposit
cell
detect
immunohistochemistri
tissu
although
tissu
usual
histolog
normal
without
accompani
inflammatori
respons
rel
constant
exposur
cmv
antigen
probabl
explain
pattern
antivir
immun
respons
observ
longterm
infect
monkey
antibodi
titer
cellular
respons
stay
rel
stabl
time
endpoint
antibodi
titer
total
viral
antigen
prepar
hover
around
plateau
level
achiev
end
primari
infect
cellular
respons
rhcmv
antigen
also
exhibit
littl
fluctuat
mainten
stabl
virushost
relationship
ie
diseas
requir
consider
expenditur
immunolog
repertoir
infect
host
memori
tlymphocyt
respect
shown
cmvspecif
healthi
cmvposit
rhesu
macaqu
pitcher
et
al
compar
high
frequenc
cmvspecif
memori
cell
observ
persist
infect
human
waldrop
et
al
waldrop
et
al
three
condit
hcmv
seriou
pathogen
immunodefici
immunosuppress
intrauterin
infect
strong
parallel
nhp
condit
summar
first
publish
descript
cmv
diseas
nhp
occur
context
rhesu
macaqu
coinfect
type
simian
retroviru
srv
lentiviru
simian
immunodefici
viru
siv
henrickson
et
al
king
et
al
lerch
et
al
letvin
et
al
letvin
et
al
osborn
et
al
acquir
immunodefici
diseas
caus
srv
siv
character
persist
lymphadenopathi
sever
wast
chronic
diarrhea
high
morbid
mortal
multipl
opportunist
infect
includ
activ
cmv
activ
cmv
diseas
gener
character
abund
cytomegal
cell
contain
cytoplasm
andor
intranuclear
inclus
often
associ
tissu
necrosi
neutrophil
infiltr
tissu
pattern
cmv
infect
immunodefici
monkey
distinct
pauciti
viral
inclus
healthi
macaqu
strikingli
similar
cmv
diseas
human
aid
patient
incid
cmv
diseas
monkey
said
caus
siv
srv
variabl
studi
report
onethird
onehalf
cmv
seroposit
anim
evid
cmv
diseas
necropsi
baskin
et
al
kaur
et
al
king
et
al
kuhn
et
al
osborn
et
al
similar
hcmv
activ
simian
cmv
observ
multipl
tissu
baskin
howev
cmv
diseas
alway
system
occur
singl
tissu
sequar
et
al
cmv
retin
import
clinic
problem
human
aid
patient
describ
said
monkey
multipl
distinct
cours
rhcmv
infect
immunodefici
immunocompet
host
notabl
chang
includ
increas
frequenc
detect
rhcmv
dna
blood
elev
genom
copi
number
tissu
declin
measur
anticmv
immun
function
ctl
activ
cytokin
secret
neutral
antibodi
titer
kaur
et
al
sequar
et
al
kinet
chang
variabl
siv
infect
occur
primari
phase
rhcmv
infect
onset
rhcmv
diseas
said
rapid
week
post
siv
monkey
inocul
siv
persist
phase
rhcmv
infect
time
death
greatli
extend
week
year
one
studi
observ
statist
signific
decreas
time
death
anim
rhcmv
endorgan
diseas
compar
anim
without
histolog
evid
activ
rhcmv
kaur
et
al
cmv
sequela
also
observ
immunosuppress
nhp
receiv
either
allograft
xenograft
although
mani
refer
literatur
occurr
activ
cmv
transplantrecipi
appear
relat
use
intens
immunosuppress
regim
cyclophosphamid
corticosteroid
andor
antithymocyt
globulin
design
prevent
graft
reject
transplant
recipi
develop
cmv
histopatholog
similar
cmv
diseas
human
allograft
recipi
includ
pneumon
vasculopathi
ghanekar
et
al
mueller
et
al
ohtaki
et
al
ohtaki
et
al
teranishi
et
al
studi
requir
determin
util
nhp
experiment
model
studi
transplantationassoci
cmv
diseas
primarili
frequenc
cmv
reactiv
set
known
rhcmv
caus
rang
development
defect
experiment
inocul
rhesu
macaqu
fetus
almost
ident
observ
human
infant
congenit
infect
hcmv
stress
fetal
infect
nhp
model
intrauterin
pathogenesi
transplacent
transmiss
studi
report
document
either
natur
experiment
maternalfet
cmv
transmiss
nhp
publish
studi
cmvinduc
fetal
diseas
requir
direct
utero
inocul
fetus
viru
chang
et
al
london
et
al
tarant
et
al
use
ultrasound
guidanc
needl
direct
abdomin
wall
dam
deliv
viru
precis
locat
within
develop
fetu
defin
stage
gestat
growth
development
outcom
prospect
monitor
ultrasound
fetal
sampl
blood
amniot
fluid
tissu
obtain
needl
biopsi
rhesu
macaqu
fetus
inocul
rhcmv
intramniot
ia
intracrani
ic
intraperiton
ip
rout
late
first
trimest
gestat
day
midgest
day
chang
et
al
london
et
al
tarant
et
al
mild
sever
fetal
outcom
observ
approxim
inocul
fetus
rhcmv
sequela
ever
observ
dam
although
suggest
evid
retrograd
transmiss
viru
across
placenta
london
et
al
develop
brain
highli
sensit
cmv
diseas
spectrum
development
abnorm
includ
microcephali
lissencephali
ventricular
dilat
leptomening
enceph
periventricular
calcif
hallmark
congenit
hcmv
infect
alford
britt
rhcmv
histopatholog
limit
brain
system
effect
intrauterin
growth
restrict
dissemin
rhcmv
diseas
isol
viru
blood
tissu
seen
chang
et
al
tarant
et
al
placent
abnorm
decidu
infarct
calcif
lymphocyt
infiltr
seen
inocul
fetus
london
et
al
cercopithecin
herpesviru
gener
refer
herp
b
viru
bv
alphaherpesviru
rhesu
macaqu
strong
genet
virolog
immunolog
related
herp
simplex
viru
hsv
human
bv
infect
rhesu
monkey
seem
accur
model
hsv
infect
human
deadli
zoonot
potenti
bv
prevent
use
anim
model
howev
recent
list
categor
pathogen
us
public
health
servic
could
agent
bioterror
thu
brief
discuss
bv
includ
bv
endem
asian
macaqu
popul
weigler
close
relat
alphaherpesvir
variant
present
african
nhp
eberl
hilliard
bv
deservedli
bear
attent
nhp
alphaherpesvirus
pathogen
potenti
human
zoonot
infect
human
b
viru
almost
invari
fatal
absenc
antivir
chemotherapi
sever
nonfat
infect
result
encephalomyel
sever
neurolog
impair
bv
simian
herpesviru
known
caus
diseas
human
salient
featur
bv
natur
histori
term
occup
risk
overwhelm
major
macaqu
shed
b
viru
without
overt
sign
diseas
huff
je
et
al
weigler
et
al
zwartouw
boulter
thu
everi
bvseroposit
macaqu
must
consid
potenti
sourc
infecti
bv
whether
bodili
fluid
tissu
despit
preced
risk
assess
approxim
document
case
human
infect
sinc
first
report
transmiss
human
disproportion
number
zoonot
infect
high
seropreval
bv
breed
age
anim
function
bv
life
cycl
biolog
bv
infect
macaqu
character
lifelong
persist
infrequ
usual
subclin
shed
mucos
surfac
although
natur
histori
bv
describ
detail
replic
cycl
hsv
serv
preced
roizman
sear
viru
transmit
across
mucos
surfac
oral
genit
mucosa
follow
local
replic
mucos
epitheli
cell
viru
transmit
directli
sensori
nerv
end
prevail
thought
associ
bloodborn
stage
infect
except
rare
system
infect
simon
et
al
viru
particl
carri
axon
transport
dorsal
root
ganglia
viru
establish
true
latent
infect
neuron
latenc
note
lack
viral
replic
extrem
limit
pattern
viral
transcript
period
reactiv
latenc
result
product
progeni
virion
transport
back
axon
mucos
epitheli
cell
replic
infecti
viru
releas
mucos
epithelium
bv
episod
recurr
viral
shed
asymptomat
weigler
et
al
zwartouw
boulter
repres
constant
risk
zoonos
clinic
sign
either
primari
recurr
infect
oral
herpet
lesion
gingivostomat
oral
lingual
ulcer
conjunct
except
carlson
et
al
keebl
et
al
weigler
usual
requir
immedi
euthanasia
anim
viru
isol
molecular
detect
bv
dna
indic
frequenc
shed
popul
low
although
studi
need
establish
true
rate
evid
suggest
shed
frequenc
may
go
breed
season
weigler
et
al
strong
correl
seroconvers
bv
age
anim
seroconvers
rate
increas
sharpli
monkey
reach
age
sexual
matur
preval
rate
adult
popul
weigler
weigler
et
al
evid
vertic
transmiss
bv
human
b
viru
infect
gener
involv
direct
contact
macaqu
tissu
fluid
method
contact
includ
bite
scratch
contact
mucos
surfac
macaqu
bodi
fluid
tissu
contamin
needl
punctur
cage
scratch
one
document
case
humantohuman
transmiss
although
potenti
secondari
transmiss
probabl
low
holm
et
al
bv
diseas
begin
within
day
month
although
diseas
progress
variabl
term
kinet
clinic
sign
guidelin
reduc
potenti
exposur
treatment
suspect
bv
infect
human
recent
publish
holm
et
al
hepat
b
viru
hbv
small
doubleshel
hepadenaviru
viru
contain
partial
doublestrand
dna
genom
approxim
base
found
sever
speci
includ
woodchuck
ground
squirrel
rang
bird
speci
duck
goos
grey
heron
marion
et
al
mason
et
al
summer
et
al
nhp
chimpanze
pan
troglodyt
woolli
monkey
lagothrix
lagothrica
orangutan
pongo
pygmaeu
gibbon
hylob
sp
gorilla
gorilla
gorilla
greth
et
al
lanford
et
al
mimm
et
al
vaudin
et
al
warren
et
al
hbv
isol
gibbon
chimpanze
share
earli
phylogenet
lineag
indic
virus
indigen
respect
host
norder
et
al
despit
speci
specif
natur
hbv
isol
experiment
infect
chimpanze
human
gibbon
hbv
accomplish
gallagh
gibbon
infect
experiment
exposur
human
saliva
contain
hbv
bancroft
et
al
scott
et
al
replic
human
hbv
number
primat
speci
suggest
natur
hbv
crosstransmiss
occur
hbv
present
blood
bodi
fluid
includ
salivanasopharyng
fluid
semen
cervic
secret
leukocyt
alter
et
al
davison
f
et
al
howev
hbv
transmiss
gibbon
chimpanze
human
never
document
cell
mediat
viral
clearanc
acut
hbv
infect
chimpanze
thimm
et
al
hepat
c
viru
hcv
member
flavivirida
famili
singlestrand
posit
sens
rna
genom
chimpanze
experiment
anim
suscept
infect
hepat
c
viru
hcv
chimpanze
model
hcv
infect
instrument
initi
studi
nona
nonb
hepat
includ
observ
clinic
cours
infect
determin
physic
properti
viru
eventu
clone
hcv
nucleic
acid
review
lanford
bigger
nhp
model
hcv
develop
use
surrog
virus
gb
virusb
review
beam
et
al
gb
virusb
viru
close
relat
hcv
hepatotrop
addit
level
gbvb
viremia
observ
infect
tamarin
anim
model
gbvb
greater
higher
hcv
tamarin
much
easier
hous
chimpanze
tissu
cultur
system
gbvb
use
primari
tamarin
hepatocyt
avail
beam
et
al
thu
primat
like
play
import
role
develop
effect
hcv
vaccin
earli
success
develop
effect
antibiot
vaccin
provid
hope
modern
medic
advanc
would
minim
impact
infecti
diseas
human
health
research
effort
could
shift
meet
challeng
chronic
degen
diseas
human
howev
aid
epidem
emerg
multidrug
resist
tuberculosi
numer
emerg
diseas
viral
etiolog
includ
sar
hantaviru
west
nile
viru
etc
made
clear
infecti
diseas
still
capac
alter
human
societi
dramat
thu
infecti
diseas
research
remain
high
prioriti
nhp
model
human
viral
diseas
remain
critic
tool
understand
pathogenesi
develop
vaccin
therapi
viral
agent
major
public
health
challeng
